Two out of the three major indices are trading lower today with the

Dow Jones Industrial Average

(

^DJI

) trading down 23 points (-0.1%) at 15,979 as of Tuesday, Sept. 29, 2015, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,349 issues advancing vs. 1,636 declining with 166 unchanged.

The Health Services industry currently sits down 0.3% versus the S&P 500, which is up 0.1%. Top gainers within the industry include

Thermo Fisher Scientific

(

TMO

), up 1.6%, and

Anthem

(

ANTM

), up 1.5%. A company within the industry that fell today was

Fresenius Medical Care AG & Co. KGaA

(

FMS

), up 1.7%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3.

Baxter International

(

BAX

) is one of the companies pushing the Health Services industry higher today. As of noon trading, Baxter International is up $0.52 (1.6%) to $33.11 on average volume. Thus far, 4.1 million shares of Baxter International exchanged hands as compared to its average daily volume of 10.5 million shares. The stock has ranged in price between $32.22-$33.25 after having opened the day at $32.53 as compared to the previous trading day's close of $32.59.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Baxter International Inc., develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $18.8 billion and is part of the health care sector. The company has a P/E ratio of 10.9, below the S&P 500 P/E ratio of 24.4. Shares are down 11.1% year-to-date as of the close of trading on Monday. Currently there is 1 analyst who rates Baxter International a buy, no analysts rate it a sell, and 11 rate it a hold.

TheStreet Ratings rates

Baxter International

as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, attractive valuation levels, expanding profit margins, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company has had somewhat weak growth in earnings per share. Get the full

Baxter International Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

2. As of noon trading,

Express Scripts

(

ESRX

) is up $0.72 (0.9%) to $80.72 on average volume. Thus far, 2.0 million shares of Express Scripts exchanged hands as compared to its average daily volume of 4.3 million shares. The stock has ranged in price between $80.08-$81.77 after having opened the day at $80.44 as compared to the previous trading day's close of $80.00.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company operates through two segments, PBM and Other Business Operations. Express Scripts has a market cap of $54.4 billion and is part of the health care sector. The company has a P/E ratio of 26.7, above the S&P 500 P/E ratio of 24.4. Shares are down 5.5% year-to-date as of the close of trading on Monday. Currently there are 12 analysts who rate Express Scripts a buy, no analysts rate it a sell, and 9 rate it a hold.

TheStreet Ratings rates

Express Scripts

as a

buy

. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, good cash flow from operations and solid stock price performance. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full

Express Scripts Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

1. As of noon trading,

Medtronic

(

MDT

) is up $2.48 (3.8%) to $67.00 on heavy volume. Thus far, 6.3 million shares of Medtronic exchanged hands as compared to its average daily volume of 5.9 million shares. The stock has ranged in price between $64.95-$68.01 after having opened the day at $65.02 as compared to the previous trading day's close of $64.52.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Medtronic plc manufactures and sells device-based medical therapies worldwide. Medtronic has a market cap of $94.0 billion and is part of the health care sector. The company has a P/E ratio of 31.1, above the S&P 500 P/E ratio of 24.4. Shares are down 10.6% year-to-date as of the close of trading on Monday. Currently there are 14 analysts who rate Medtronic a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates

Medtronic

as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, good cash flow from operations and solid stock price performance. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full

Medtronic Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care

(

RXD

).